Leukemia; Scientists at Roswell Park Cancer Institute Target Leukemia
Leukemia; Scientists at Roswell Park Cancer Institute Target Leukemia
About this item
Full title
Leukemia; Scientists at Roswell Park Cancer Institute Target Leukemia
Publisher
Atlanta: NewsRx
Journal title
Obesity, Fitness & Wellness Week, 2011, p.1725
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
"However, the introduction of imatinib and related tyrosine kinase inhibitors (TKIs) abated the clinical development of omacetaxine as a treatment for CML. The advent of resistance to imatinib and other TKIs in CML patients (often due to the presence of an ABL mutation at position 315) has led to a revived clinical interest in omacetaxine in CML pa...
Alternative Titles
Full title
Leukemia; Scientists at Roswell Park Cancer Institute Target Leukemia
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_865815756
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_865815756
Other Identifiers
ISSN
1531-6386
E-ISSN
1532-4664
How to access this item
Log in as a Library member
